Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EWING 2008
2008-003658-13Phase 3Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Aug 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of busulfan in Ewing sarcoma and neuroectodermal tumor, sponsored by Universitätsklinikum Münster. Primary endpoint: Event-free survival. Started Aug 2008; status: completed.
02
Drugs
busulfan
03
Conditions
Ewing sarcomaneuroectodermal tumor
Beyond the preview
Go deeper on 2008-003658-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003658-13.